36552550|t|Thiocyanate Reduces Motor Impairment in the hMPO-A53T PD Mouse Model While Reducing MPO-Oxidation of Alpha Synuclein in Enlarged LYVE1/AQP4 Positive Periventricular Glymphatic Vessels.
36552550|a|Parkinson's disease (PD) is due to the oxidation of alpha synuclein (alphaSyn) contributing to motor impairment. We developed a transgenic mouse model of PD that overexpresses the mutated human alphaSyn gene (A53T) crossed to a mouse expressing the human MPO gene. This model exhibits increased oxidation and chlorination of alphaSyn leading to greater motor impairment. In the current study, the hMPO-A53T mice were treated with thiocyanate (SCN-) which is a favored substrate of MPO as compared to chlorine. We show that hMPO-A53T mice treated with SCN- have less chlorination in the brain and show an improvement in motor skills compared to the nontreated hMPO-A53T mice. Interestingly, in the hMPO-A53T mice we found a possible link between MPO-related disease and the glymphatic system which clears waste including alphaSyn from the brain. The untreated hMPO-A53T mice exhibited an increase in the size of periventricular glymphatic vessels expressing the glymphatic marker LYVE1 and aquaporin 4 (AQP4). These vessels also exhibited an increase in MPO and HOCl-modified epitopes in the glymphatic vessels correlating with loss of ependymal cells lining the ventricles. These findings suggest that MPO may significantly promote the impairment of the glymphatic waste removal system thus contributing to neurodegeneration in PD. Moreover, the inhibition of MPO chlorination/oxidation by SCN- may provide a potential therapeutic approach to this disease.
36552550	0	11	Thiocyanate	Chemical	MESH:C031760
36552550	20	36	Motor Impairment	Disease	MESH:D000068079
36552550	49	53	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:9606;CA#:257068
36552550	54	56	PD	Disease	MESH:D010300
36552550	57	62	Mouse	Species	10090
36552550	84	87	MPO	Gene	17523
36552550	101	116	Alpha Synuclein	Gene	20617
36552550	129	134	LYVE1	Gene	114332
36552550	135	139	AQP4	Gene	11829
36552550	185	204	Parkinson's disease	Disease	MESH:D010300
36552550	206	208	PD	Disease	MESH:D010300
36552550	237	252	alpha synuclein	Gene	6622
36552550	254	262	alphaSyn	Gene	6622
36552550	280	296	motor impairment	Disease	MESH:D000068079
36552550	324	329	mouse	Species	10090
36552550	339	341	PD	Disease	MESH:D010300
36552550	373	378	human	Species	9606
36552550	379	387	alphaSyn	Gene	6622
36552550	394	398	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:9606;CA#:257068
36552550	413	418	mouse	Species	10090
36552550	434	439	human	Species	9606
36552550	440	443	MPO	Gene	4353
36552550	510	518	alphaSyn	Gene	6622
36552550	538	554	motor impairment	Disease	MESH:D000068079
36552550	582	591	hMPO-A53T	CellLine	CVCL:RD28
36552550	592	596	mice	Species	10090
36552550	615	626	thiocyanate	Chemical	MESH:C031760
36552550	628	632	SCN-	Chemical	MESH:C031760
36552550	666	669	MPO	Gene	17523
36552550	685	693	chlorine	Chemical	MESH:D002713
36552550	713	717	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:9606;CA#:257068
36552550	718	722	mice	Species	10090
36552550	736	740	SCN-	Chemical	MESH:C031760
36552550	849	853	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:9606;CA#:257068
36552550	854	858	mice	Species	10090
36552550	887	891	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:9606;CA#:257068
36552550	892	896	mice	Species	10090
36552550	930	933	MPO	Gene	17523
36552550	1005	1013	alphaSyn	Gene	20617
36552550	1044	1053	hMPO-A53T	CellLine	CVCL:RD28
36552550	1054	1058	mice	Species	10090
36552550	1164	1169	LYVE1	Gene	114332
36552550	1174	1185	aquaporin 4	Gene	11829
36552550	1187	1191	AQP4	Gene	11829
36552550	1238	1241	MPO	Gene	17523
36552550	1246	1250	HOCl	Chemical	MESH:D006997
36552550	1387	1390	MPO	Gene	17523
36552550	1492	1509	neurodegeneration	Disease	MESH:D019636
36552550	1513	1515	PD	Disease	MESH:D010300
36552550	1545	1548	MPO	Gene	17523
36552550	1575	1579	SCN-	Chemical	MESH:C031760
36552550	Association	MESH:D006997	17523
36552550	Association	MESH:D010300	RS#:104893877;HGVS:p.A53T;CorrespondingGene:6622
36552550	Negative_Correlation	MESH:C031760	RS#:104893877;HGVS:p.A53T;CorrespondingGene:6622
36552550	Association	MESH:D019636	17523
36552550	Association	114332	17523
36552550	Association	4353	6622
36552550	Association	17523	20617
36552550	Negative_Correlation	MESH:C031760	20617
36552550	Negative_Correlation	MESH:C031760	17523
36552550	Association	11829	17523
36552550	Association	MESH:D010300	17523
36552550	Association	MESH:D010300	6622
36552550	Association	MESH:D000068079	6622
36552550	Negative_Correlation	MESH:C031760	MESH:D000068079
36552550	Association	11829	20617
36552550	Association	MESH:D010300	6622

